A recent meta-analysis of 69 clinical trials found the risk for ischemic optic neuropathy from GLP-1 therapy is too low to be ...
including nonarteritic anterior ischemic optic neuropathy, neuromyelitis optica, inflammatory optic neuropathies (sarcoid, lupus and giant cell arteritis), infectious optic neuropathies (Lyme ...